The t(8;21) is one of the most frequent chromosomal translocations associated with acute myeloid leukemia (AML). It fuses the DNA binding domain of AML1 (RUNX1) to nearly all of ETO (MTG8). However, an alternatively spliced form of AML1-ETO termed "9a", which deletes the C-terminal NH3 and NH4 conserved domains of ETO, is much more leukemogenic when expressed in murine stem and myeloid progenitor cells. The C-terminal domains of ETO/MTG family members also suffer point mutations in solid tumors and the NH4 domain of MTG16 is deleted by the inv(16)(p13.3q24.3), which fuses MTG16 to GLIS2. The short latency and high penetrance of AML caused by AE9a and the inactivation of NH4 in other cancers, suggests that proteins associating with the C-terminus of MTGs and AML1-ETO provide a barrier to tumor/leukemia development. Yeast two-hybrid (Y2H) screens using MTG family members identified factors that regulate RNA Pol II pausing and elongation that associated with the C-terminus of MTGs, which is deleted in the AE9a isoform. Analysis of Mtg16-/- and Mtg8-/- knockout mice suggested that these factors are key mediators of the knock out phenotypes and that MTGs are negative regulators of transcription elongation. In addition, cancer-associated point mutations disrupt the association between MTGs or AML1-ETO and elongation factors, further suggesting that the association of AML1-ETO or MTGs with elongation factors mediates the barrier to leukemia. Therefore, we hypothesize that AE9a releases elongation factors from negative regulation to promote AML development. This hypothesis will be directly tested genetically using cancer-associated point mutations that affect binding to elongation factors and by the use of innovative methods that measure RNA polymerase II pausing and elongation. We also hypothesize that these data begin to explain why t(8;21) containing cells are so sensitive to inhibitors that target transcriptional elongation and we will directly test this hypothesis by measuring how these drugs affect transcription in t(8;21)-containing cells.

Public Health Relevance

The t(8;21) occurs in roughly 10% of the acute myeloid leukemia cases and about half of these patients will suffer relapse with a poor prognosis. This work will define how the fusion protein made by this chromosomal translocation causes leukemia. We will use this information to test new therapeutic strategies for the treatment of this deadly disease, and at the same time determine how these new drugs work, so that we can better use these compounds in the future.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Cancer Genetics Study Section (CG)
Program Officer
Mufson, R Allan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Schools of Medicine
United States
Zip Code
Summers, Alyssa R; Fischer, Melissa A; Stengel, Kristy R et al. (2013) HDAC3 is essential for DNA replication in hematopoietic progenitor cells. J Clin Invest 123:3112-23
Wells, Christina E; Bhaskara, Srividya; Stengel, Kristy R et al. (2013) Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One 8:e68915
Fischer, Melissa A; Moreno-Miralles, Isabel; Hunt, Aubrey et al. (2012) Myeloid translocation gene 16 is required for maintenance of haematopoietic stem cell quiescence. EMBO J 31:1494-505
Hunt, Aubrey; Fischer, Melissa; Engel, Michael E et al. (2011) Mtg16/Eto2 contributes to murine T-cell development. Mol Cell Biol 31:2544-51
Barrett, Caitlyn W; Fingleton, Barbara; Williams, Amanda et al. (2011) MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Cancer Res 71:1302-12
Bhaskara, Srividya; Knutson, Sarah K; Jiang, Guochun et al. (2010) Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell 18:436-47
Yan, Ming; Ahn, Eun-Young; Hiebert, Scott W et al. (2009) RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood 113:883-6
Bhaskara, Srividya; Chyla, Brenda J; Amann, Joseph M et al. (2008) Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control. Mol Cell 30:61-72
Moore, Amy C; Amann, Joseph M; Williams, Christopher S et al. (2008) Myeloid translocation gene family members associate with T-cell factors (TCFs) and influence TCF-dependent transcription. Mol Cell Biol 28:977-87
Hanson, Caroline A; Wood, Lauren D; Hiebert, Scott W (2008) Cellular stress triggers TEL nuclear export via two genetically separable pathways. J Cell Biochem 104:488-98

Showing the most recent 10 out of 56 publications